{"id":"NCT02692755","sponsor":"Georgetown University","briefTitle":"Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer","officialTitle":"Phase II Safety Study of Palbociclib in Combination With Letrozole or Fulvestrant in African American Women With Hormone Receptor Positive HER2 Negative Advanced Breast Cancer","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2016-09","primaryCompletion":"2019-12-16","completion":"2021-03-23","firstPosted":"2016-02-26","resultsPosted":"2021-08-20","lastUpdate":"2021-09-28"},"enrollment":35,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hormone Receptor Positive HER-2 Negative Breast Cancer"],"interventions":[{"type":"DRUG","name":"Palbociclib + Letrozole or Fulvestrant","otherNames":["Ibrance","Femara","Faslodex"]}],"arms":[{"label":"Palbociclib + Letrozole or Fulvestrant","type":"EXPERIMENTAL"}],"summary":"This study aims to evaluate the hematological safety of palbociclib with letrozole and fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer. Hematological safety is a composite endpoint of episodes of febrile neutropenia and treatment discontinuation due to neutropenia according to current recommendations for management of neutropenia","primaryOutcome":{"measure":"Number of Patients Who Complete Planned Oncologic Therapy Without the Development of a Hematological Event","timeFrame":"12 months","effectByArm":[{"arm":"Palbociclib + Letrozole or Fulvestrant","deltaMin":35,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":["20610543","15894097","3611201","6871841","12775735","19874578","21610706","22090362","25501126","25524798","26488700","24643646","17404350","19180233","20194862","14559877","25693144","25864878","26330356","25339305","20959483","26467503","26452221","26432333","25077924","17170061","23078175","34157782"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":35},"commonTop":["Neutrophil count decreased","Fatigue","Anemia","White blood cell decreased","Abdominal Pain"]}}